waypoint wealth counsel »

Alnylam Pharmaceuticals shares owned by waypoint wealth counsel

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by waypoint wealth counsel from 13F filings

Historical chart of waypoint wealth counsel investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by waypoint wealth counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by waypoint wealth counsel

Quarter filed Position value Share count Share price at filing
2025-12-31 $356k 895 397.66
2025-09-30 $283k 621 456.00